DOXAmdocs Limited

$62.73-23% 1Y
Latest close: below its 200-day averageOct 23, 2026what changed →

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap vs its sector.

2 good, 1 without data
What the price assumes~−3% a year

Priced for a decline (~−3% a year). Little growth is priced in even as revenue fell 0% a year over three years, potential value, or a value trap.

Vs sector (EV/EBIT)9.7×

Sector median 29.4× across 209 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

All from derived, as of Sep 30, 2025.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 81% of the market
FCF yieldbetter than 84% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What DOX's price assumes

Amdocs Limited trades at 12.4× earnings against 35.0× for the median Software - Infrastructure name, cheaper than its own group.

12.4

Trailing P/E · Software - Infrastructure median 35.0 · cheaper than the typical name in its group

Price / sales
1.50

Price / sales · today's price, fiscal year to Sep 30, 2025

Free cash flow yield
9.5%

Free cash flow yield · Software - Infrastructure median 4.9%

Growth the price implies
−2.9%

Growth the price implies · The price pays for −2.9% free cash flow growth a year for a decade; the business has delivered +6.8% a year over the last three.

Details›
Price / booktoday's price, fiscal year to Sep 30, 2025
1.98
EV / EBITtoday's price, fiscal year to Sep 30, 2025
9.74
EV / salestoday's price, fiscal year to Sep 30, 2025
1.57
Technology median P/E450 names
34.1
Software - Infrastructure median P/E103 names
35.0
Free cash flow, trailing twelve months
$645M
Market capitalisation108.4 million shares, counted Sep 30, 2025
$6.80B
3-year revenue growth
−0.32%
3-year free cash flow growth
+6.8%

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.